Efficacy and Prognostic Indicators of Isatuximab, Pomalidomide, and Dexamethasone (isapd) in Daratumumab-Refractory Multiple Myeloma Patients: A Multicenter Real-World Study.
HEMATOLOGICAL ONCOLOGY（2025）
关键词
dara-refractory,dexamethasone,isatuximab,multiple myeloma,pomalidomide,salvage therapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要